Evaluation of Safety, Tolerability and Preliminary Efficacy of EHP-101 in Relapsing Forms of Multiple Sclerosis
Clinical trial NCT04909502 · SUSPENDED
Trial details
- NCT number
- NCT04909502
- Sponsor
- Emerald Health Pharmaceuticals
- Status
- SUSPENDED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-19
- Primary completion
- 2023-12-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.